Effectiveness of fibroblast growth factor 23 lowering modalities in chronic kidney disease: a systematic review and meta-analysis
High fibroblast growth factor 23 (FGF23) level in patients with chronic kidney disease is associated with increased cardiovascular disease and mortality. phosphate binders, iron supplements, calcimimetics, parathyroidectomy, dialysis techniques, and preservation of residual renal function (RRF) were found to be effective.

Related Post